Prospective Cohort With Hemopathy in Languedoc-Roussillon

Recruiting

• Conditions: Hematologic Malignancy
• Interventions: Biological: hematologic malignancy

• Registration Number: NCT02134574
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

Prospective Cohort Study of clinical and laboratory data of patients with hemopathy.

Detailed Description

Prospective Cohort Study of clinical and laboratory data of patients with hemopathy in LR.

Study Timeline

• Study Start: 2014-02
• Study First Submitted: 2014-04-22
• Study First Submitted QC: 2014-05-06
• Study First Posted: 2014-05-09
• Status Verified: 2021-12
• Last Update Submitted: 2021-12-31
• Last Update Posted: 2022-01-04
• Primary Completion: 2033-06
• Study Completion: 2033-06

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
hematologic malignancy	hematologic malignancy	hematologic malignancy with a sampling of blood

Primary Outcome Measures

Name	Time	Method
Survival with 2 years	2 years	Prospective Cohort Study of clinical and biological data Analysis Biological, clinical and questionnaire EORTC_QLQ-C30

Secondary Outcome Measures

Name	Time	Method
Survival with 10 years	10 years	Prospective Cohort Study of clinical and biological data Analysis Biological, clinical and questionnaire EORTC_QLQ-C30
Survival with 5 years	5 years	Prospective Cohort Study of clinical and biological data Analysis Biological, clinical and questionnaire EORTC_QLQ-C30

Trial Locations

Locations (1)

Hematology department - UHMontpellier Saint éloi; 🇫🇷 Montpellier, France